Therapeutic Asset Ratings
482 results matching 1 filter
133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Everolimus
Colorectal Cancer
Second Affiliated Hospital, School of Medicine, Zhejiang University
P2
B
(60)
Fludarabine
Colorectal Cancer
University of Pennsylvania
P2
B
(60)
Gm-Csf
Colorectal Cancer
Brenus Pharma
P2
B
(60)
Palbociclib
Colorectal Cancer
Lebanese University
P2
B
(60)
Atezolizumab
Colorectal Cancer
Exelixis
P3
B
(59)
Bms-907351
Colorectal Cancer
Exelixis
P3
B
(59)
CIS-DIAMMINEDICHLOROPLATINUM II
Colorectal Cancer
Tianjin Medical University Cancer Institute and Hospital
P3
B
(59)
ETOPOSIDE
Colorectal Cancer
Biotheus Inc.
P3
B
(59)
Floxuridine
Colorectal Cancer
ECOG-ACRIN Cancer Research Group
P3
B
(59)
Inno-206
Colorectal Cancer
Junpeng Wang
P3
B
(59)
Huaier Granule
Colorectal Cancer
Fudan University
P4
B
(58)
METRONIDAZOLE
Colorectal Cancer
Virginia Commonwealth University
P4
B
(58)
NEOMYCIN
Colorectal Cancer
M.D. Anderson Cancer Center
P4
B
(58)
Carboplatin
Colorectal Cancer
Revolution Medicines, Inc.
P3
B
(58)
Cytosin-Arabinosid
Colorectal Cancer
Liaoning Medical Diagnosis and Treatment Technology Research and Development Co., Ltd.
P3
B
(58)
IMMUNOGLOBULIN G1, ANTI-(HUMANIZED MOUSE MONOCLONAL HR3 .BETA.1 CHAIN ANTI-HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR), DISULFIDE WITH HUMANIZED MOUSE MONOCLONAL HR3 .KAPPA.-CHAIN, DIMER
Colorectal Cancer
Chinese PLA General Hospital
P3
B
(58)
Olaparib
Colorectal Cancer
Grupo Espanol Multidisciplinario del Cancer Digestivo
P3
B
(58)
Telisotuzumab Adizutecan
Colorectal Cancer
AbbVie
P3
B
(58)
Binimetinib
Colorectal Cancer
Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)
P2
B
(58)
Docetaxel
Colorectal Cancer
NuCana plc
P2
B
(58)
IMMUNOGLOBULIN G2, ANTI-(HUMAN CTLA-4 (ANTIGEN)) (HUMAN MONOCLONAL CP-675206 CLONE 11.2.1 HEAVY CHAIN) DISULPHIDE WITH HUMAN MONOCLONAL CP-675206 CLONE 11.2.1 LIGHT CHAIN, DIMER
Colorectal Cancer
Vall d'Hebron Institute of Oncology
P2
B
(58)
Trastuzumab Deruxtecan
Colorectal Cancer
M.D. Anderson Cancer Center
P2
B
(58)
ROPIVACAINE
Colorectal Cancer
Tri-Service General Hospital
P4
B
(57)
Famitinib
Colorectal Cancer
Huazhong University of Science and Technology
P3
B
(57)
Indocyanine Green
Colorectal Cancer
Vadim Kuznetsov
P3
B
(57)
Showing 51 to 75 of 482 assets
Previous
Page 3 of 20
Next